1.16
+0.02(+1.75%)
Currency In USD
| Previous Close | 1.14 |
| Open | 1.15 |
| Day High | 1.21 |
| Day Low | 1.11 |
| 52-Week High | 2.74 |
| 52-Week Low | 0.36 |
| Volume | 2.61M |
| Average Volume | 5.14M |
| Market Cap | 139.14M |
| PE | -1.26 |
| EPS | -0.92 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 0.76 |
| Change | 0.02 |
If you invested $1000 in Invivyd, Inc. (IVVD) since IPO date, it would be worth $55.56 as of September 08, 2025 at a share price of $1.16. Whereas If you bought $1000 worth of Invivyd, Inc. (IVVD) shares 3 years ago, it would be worth $250.54 as of September 08, 2025 at a share price of $1.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
GlobeNewswire Inc.
Sep 04, 2025 11:01 AM GMT
SPEAR proposal reflects current evidence on monoclonal antibodies in treatment for Long COVID and identifies VYD2311 as a promising next-generation candidate for the clinical study Recommendation is for a robust, comprehensive, translational study to
Invivyd to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Aug 27, 2025 11:01 AM GMT
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025Fireside Chat Date: Wednesday, September 3, 2025Fires
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
GlobeNewswire Inc.
Aug 22, 2025 4:00 PM GMT
WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the closing of its previously announced underwritten public offering of 89,234,480 shares of its common stock, which includes the exercise in f